Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis.

Yu HY, Lee CY, Hu YC, Lin LG, Chao Y, Li CP

Open source

DOI
10.1186/s12885-025-13896-5
Published
2025 Mar 19
Container
BMC cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12885-025-13896-5,
  title = {Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis.},
  author = {Yu HY and Lee CY and Hu YC and Lin LG and Chao Y and Li CP},
  year = {2025},
  journal = {BMC cancer},
  doi = {10.1186/s12885-025-13896-5},
  url = {https://doi.org/10.1186/s12885-025-13896-5}
}

RIS

TY  - JOUR
TI  - Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis.
AU  - Yu HY
AU  - Lee CY
AU  - Hu YC
AU  - Lin LG
AU  - Chao Y
AU  - Li CP
PY  - 2025
JO  - BMC cancer
DO  - 10.1186/s12885-025-13896-5
UR  - https://doi.org/10.1186/s12885-025-13896-5
ER  - 

APA

HY, Y., CY, L., YC, H., LG, L., Y, C., & CP, L. (2025). Treatment rechallenge is safe and leads to better survival in pancreatic cancer patients with interstitial pneumonitis.. BMC cancer. https://doi.org/10.1186/s12885-025-13896-5

Source records